The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
Open accessAbstract
The relative contribution of the effector molecules produced by T cells to tumour rejection is unclear, but interferon-γ (IFNγ) is critical in most of the analysed models. Although IFNγ can impede tumour growth by acting directly on cancer cells, it must also act on the tumour stroma for effective rejection of large, established tumours. However, which stroma cells respond to IFNγ and by which mechanism IFNγ contributes to tumour rejection through stromal targeting have remained unknown. Here we use a model of IFNγ induction and an IFNγ–GFP fusion protein in large, vascularized tumours growing in mice that express the IFNγ receptor exclusively in defined cell types. Responsiveness to IFNγ by myeloid cells and other haematopoietic cells, including T cells or fibroblasts, was not sufficient for IFNγ-induced tumour regression, whereas responsiveness of endothelial cells to IFNγ was necessary and sufficient. Intravital microscopy revealed IFNγ-induced regression of the tumour vasculature, resulting in arrest of blood flow and subsequent collapse of tumours, similar to non-haemorrhagic necrosis in ischaemia and unlike haemorrhagic necrosis induced by tumour necrosis factor. The early events of IFNγ-induced tumour ischaemia resemble non-apoptotic blood vessel regression during development, wound healing or IFNγ-mediated, pregnancy-induced remodelling of uterine arteries. A better mechanistic understanding of how solid tumours are rejected may aid the design of more effective protocols for adoptive T-cell therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Conditional gene targeting in macrophages and granulocytes using LysMcre mice
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., & Förster, I. (1999) · Transgenic Research · doi:10.1023/a:1008942828960 · Cited by 2,098
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401
Luster, A. D., Unkeless, J. C., & Ravetch, J. V. (1985) · Nature · doi:10.1038/315672a0 · Cited by 944
Ashkar, A. A., Di Santo, J. P., & Croy, B. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.259 · Cited by 845
T-helper-1-cell cytokines drive cancer into senescence
Braumüller, H., Wieder, T., Brenner, E., Aßmann, S., Hahn, M., Alkhaled, M., Schilbach, K., Essmann, F., Kneilling, M., Griessinger, C., et al. (2013) · Nature · doi:10.1038/nature11824 · Cited by 720
Dighe, A. S., Richards, E., Old, L. J., & Schreiber, R. D. (1994) · Immunity · doi:10.1016/1074-7613(94)90087-6 · Cited by 663
Mazzieri, R., Pucci, F., Moi, D., Zonari, E., Ranghetti, A., Berti, A., Politi, L. S., Gentner, B., Brown, J. L., Naldini, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.005 · Cited by 639
Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W. (1997) · Science · doi:10.1126/science.275.5299.540 · Cited by 583
Qin, Z., & Blankenstein, T. (2000) · Immunity · doi:10.1016/s1074-7613(00)80218-6 · Cited by 511
Self-citationLuche, H., Weber, O., Nageswara Rao, T., Blum, C., & Fehling, H. J. (2007) · European Journal of Immunology · doi:10.1002/eji.200636745 · Cited by 482
Self-citationPrimary Antitumor Immune Response Mediated by CD4+ T Cells
Corthay, A., Skovseth, D. K., Lundin, K. U., Røsjø, E., Omholt, H., Hofgaard, P. O., Haraldsen, G., & Bogen, B. (2005) · Immunity · doi:10.1016/j.immuni.2005.02.003 · Cited by 478
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance
Willimsky, G., & Blankenstein, T. (2005) · Nature · doi:10.1038/nature03954 · Cited by 445
Self-citationInterferon γ Is Required for Activation-induced Death of T Lymphocytes
Refaeli, Y., Van Parijs, L., Alexander, S. I., & Abbas, A. K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020666 · Cited by 417
Interferon-γ elicits arteriosclerosis in the absence of leukocytes
Tellides, G., Tereb, D. A., Kirkiles-Smith, N. C., Kim, R. W., Wilson, J. H., Schechner, J. S., Lorber, M. I., & Pober, J. S. (2000) · Nature · doi:10.1038/35003221 · Cited by 391
Efficient, inducible Cre‐recombinase activation in vascular endothelium
Claxton, S., Kostourou, V., Jadeja, S., Chambon, P., Hodivala‐Dilke, K., & Fruttiger, M. (2008) · genesis · doi:10.1002/dvg.20367 · Cited by 327
Self-citationCoughlin, C. M., Salhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Liu, L., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80585-3 · Cited by 324
Dynamic Endothelial Cell Rearrangements Drive Developmental Vessel Regression
Franco, C. A., Jones, M. L., Bernabeu, M. O., Geudens, I., Mathivet, T., Rosa, A., Lopes, F. M., Lima, A. P., Ragab, A., Collins, R. T., et al. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002125 · Cited by 295
Self-citationRothstein, J. L., & Schreiber, H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.2.607 · Cited by 260
Self-citationMig, the Monokine Induced By Interferon-γ, Promotes Tumor Necrosis In Vivo
Sgadari, C., Farber, J. M., Angiolillo, A. L., Liao, F., Teruya-Feldstein, J., Burd, P. R., Yao, L., Gupta, G., Kanegane, C., & Tosato, G. (1997) · Blood · doi:10.1182/blood.v89.8.2635 · Cited by 246
A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells.
Qin, Z., Schwartzkopff, J., Pradera, F., Kammertoens, T., Seliger, B., Pircher, H., & Blankenstein, T. J. F. (2003) · PubMed · Cited by 235
Self-citationAugustin, H. G., Braun, K., Telemenakis, I., Modlich, U., & Kühn, W. (1995) · Europe PMC (PubMed Central) · Cited by 186
The role of tumor stroma in the interaction between tumor and immune system
Blankenstein, T. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.01.008 · Cited by 176
Self-citationTumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy
Johansson, A., Hamzah, J., Payne, C. J., & Ganss, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118296109 · Cited by 172
IFN-γ– and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers
Zhang, B., Karrison, T., Rowley, D. A., & Schreiber, H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33522 · Cited by 167
Self-citationIP-10 induces dissociation of newly formed blood vessels
Bodnar, R. J., Yates, C. C., Rodgers, M. E., Du, X., & Wells, A. H. (2009) · Journal of Cell Science · doi:10.1242/jcs.048793 · Cited by 138
Modlich, U., Kaup, F. ‐., & Augustin, H. G. (1996) · PubMed · Cited by 135
Hemmi, S., Peghini, P. L., Metzler, M., Merlin, G., Dembić, Z., & Aguet, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9901 · Cited by 102
Staveley-O’Carroll, K. F., Schell, T. D., Jimenez, M., Mylin, L. M., Tevethia, M. J., Schoenberger, S. P., & Tevethia, S. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.697 · Cited by 80
Briesemeister, D., Sommermeyer, D., Loddenkemper, C., Loew, R., Uckert, W., Blankenstein, T. J. F., & Kammertoens, T. (2010) · International Journal of Cancer · doi:10.1002/ijc.25350 · Cited by 74
Self-citationResponsiveness of Stromal Fibroblasts to IFN-γ Blocks Tumor Growth via Angiostasis
Yu, L., Yang, W. C., Qin, C., Zhang, L., Deng, J., Liu, S., & Qin, Z. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901073 · Cited by 71
IRF4 is a novel mediator for neuronal survival in ischaemic stroke
Guo, S., Zz, L., Jiang, D.-S., Lu, Y. Y., Liu, Y., Gao, L., Zhang, S.-M., Lei, H., Zhu, L.-H., Zhang, X., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.9 · Cited by 60
Schreiber, K., Rowley, D. A., Riethmüller, G., & Schreiber, H. W. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.03.001 · Cited by 59
Self-citationSchietinger, A., Arina, A., Liu, R. B., Wells, S., Huang, J., Engels, B., Bindokas, V. P., Bartkowiak, T., Lee, D. D., Herrmann, A., et al. (2013) · OncoImmunology · doi:10.4161/onci.26677 · Cited by 58
Self-citationDeng, J., Liu, X., Rong, L., Chen, N., Li, X., Yang, W. C., Lu, Y., Yan, X., Qin, C., Zhang, L., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4340 · Cited by 46
Anders, K., Buschow, C., Herrmann, A., Milojkovic, A., Loddenkemper, C., Kammertoens, T., Daniel, P. T., Yu, H., Charo, J., & Blankenstein, T. J. F. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.019 · Cited by 43
Self-citationFas expression by tumor stroma is required for cancer eradication
Listopad, J. J., Kammertoens, T., Anders, K., Silkenstedt, B., Willimsky, G., Schmidt, K., Kühl, A. A., Loddenkemper, C., & Blankenstein, T. J. F. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218295110 · Cited by 42
Self-citationLi, L.-P., Schlag, P. M., & Blankenstein, T. J. F. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.14-1695 · Cited by 30
Self-citationPreventing tumor escape by targeting a post-proteasomal trimming independent epitope
Textor, A., Schmidt, K., Kloetzel, P., Weißbrich, B., Pérez, C., Charo, J., Anders, K., Sidney, J., Sette, A., Schumacher, T. N., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160636 · Cited by 28
Self-citation
Cited by
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847
Gust, J., Hay, K. A., Hanafi, L.-A., Li, D., Myerson, D., Gonzalez-Cuyar, L. F., Yeung, C., Liles, W. C., Wurfel, M., Lopez, J. A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0698 · Cited by 1,400
“094 40–60 years 42 (66) 8 (13) 14 (22) 64 >60 years 27 (64) 7 (17) 8 (19) 42 Sex, n (%) Male 59 (63) 17 (18) 17 (18) 93 0.”
BackgroundInfluentialIFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
Ivashkiv, L. B. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0029-z · Cited by 1,358
Roles of IFN-γ in tumor progression and regression: A review
Jorgovanovic, D., Song, M., Wang, L., & Zhang, Y. (2020) · Biomarker Research · doi:10.1186/s40364-020-00228-x · Cited by 1,234
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
Metadata
- Authors
- Kammertoens, T., Friese, C., Arina, A., Idel, C., Briesemeister, D., Rothe, M., Ivanov, A., Szymborska, A., Patone, G., Kunz, S., Sommermeyer, D., Engels, B., Leisegang, M., Textor, A., Fehling, H. J., Fruttiger, M., Lohoff, M., Herrmann, A., Yu, H., Weichselbaum, R., Uckert, W., Hübner, N., Gerhardt, H., Beule, D., Schreiber, H., & Blankenstein, T.
- Venue
- Nature
- Published
- 2017-04-26
- Volume
- 545
- Issue
- 7652
- Pages
- 98-102
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2609998953
- Cited by
- 269
- References
- 39
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.